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helplessness, and suppression.Section on Immunology and Immunogenetics
The relative significance of central versus peripheralJoslin Diabetes Center
tolerance has been debated for decades, with sequen-Department of Medicine
tial waves of enthusiasm supporting either one or theBrigham and Women’s Hospital
other. Certainly, central mechanisms are important—forHarvard Medical School
example, a variety of approaches have estimated thatBoston, Massachusetts 02215
one-half to two-thirds of thymocytes that are positively
selected subsequently undergo negative selection (van
Meerwijk et al., 1997; Ignatowicz et al., 1996; Tourne etThe establishment and maintenance of immunological
al., 1997). However, central tolerance appears not to betolerance entails both central and peripheral mecha-
fool-proof as all individuals harbor lymphocytes in thenisms. The latter have been highlighted in the past
blood that can respond to self-antigens (e.g., Liblau etseveral years, mostly because of great interest in the
al., 1991; Sun et al., 1991). Therefore, peripheral mecha-activities of regulatory T cells. However, an important
nisms must be important as well. Indeed, over the pastrole for central tolerance mechanisms has been reem-
several years peripheral tolerance—in particular, the ac-phasized by recent results on human autoimmune dis-
tivities of regulatory T cells (Sakaguchi, 2004)—haveeases, including APECED and type 1 diabetes.
held the limelight.
This dichotomous view of central versus peripheralIntroduction
self-antigens and corresponding tolerance mechanismsEvery day, every individual is confronted with a myriad of
was the reigning paradigm for decades. Recently, how-microbial challenges. Inevitably, certain of the microbes
ever, this too-simplistic image has been brought intoinvade the integrity of the individual, but these are rou-
question. The major challenge has been a gradual accu-tinely disposed of by the combined forces of the innate
mulation of evidence that proteins usually consideredand adaptive immune systems. To be effective against
to be synthesized in the periphery in a tissue-specificthe many challenges encountered, T and B lymphocytes
manner have also been detected in the thymus (re-of the adaptive immune system exhibit extensive diver-
viewed in Kyewski et al., 2002). Attention was first drawnsity, generated through random rearrangement of the
to promiscuous thymic expression of transcripts encod-genes encoding antigen-specific receptors during these
ing tissue-specific proteins when it was reported that acells’ differentiation in the thymus and bone marrow,
transgene expressing SV40 T antigen under the dictatesrespectively. Since this is a random process, lympho-
of the rat insulin promoter was transcribed in the thymuscytes whose receptors can recognize one of the body’s
as well; the endogenous insulin gene was also thymicallyown constituents are sometimes generated, resulting in
expressed (Jolicoeur et al., 1994). At first, suspicions ofautoimmunity and, occasionally, autoimmune disease.
PCR contamination prevailed, but additional examplesBecause of the devastating consequences such a dis-
accrued, culminating in a listing of scores of genes en-ease can have, evolution has provided a comprehensive
coding proteins previously thought of as tissue-specificnet of mechanisms ensuring the establishment and
or tissue-restricted that are also transcribed in the thy-maintenance of lymphocyte self-tolerance.
mus (Derbinski et al., 2001). Proteins characteristic of aClassically, lymphocyte tolerance mechanisms have
variety of tissues—for example, the pancreas, liver, eye,been divided into two broad categories. Central toler-
and nervous system—were included on the list. Some
ance (Ohashi, 2003; Venanzi et al., 2004b) concerns im-
investigators still attributed this phenomenon to some
mature T or B cells as they differentiate in the primary
uninteresting, nebulous mechanism—so-called “leaky”
lymphoid organs, the thymus or bone marrow. Relevant transcription. But even they took notice when it became
antigens, then, would be those synthesized by nurturing clear that most of these promiscuous thymic transcripts
stromal cells, circulating hematopoietic cells, or, ubiqui- were restricted to a very specific component of the thy-
tously, by all cells. The major mechanisms that come mic stroma, the medullary epithelial cells (MECs) (Der-
into play during central tolerance appear to be clonal binski et al., 2001).
deletion or inactivation of self-reactive lymphocytes, in Thymic MECs are a small, heterogeneous stromal cell
particular the former. Peripheral tolerance (Walker and fraction (reviewed in Anderson and Jenkinson, 2001;
Abbas, 2002), on the other hand, relates to mature T or Gill et al., 2003). They display MHC and costimulatory
B cells after they have exited the primary lymphoid or- molecules at their surface, rendering them apt at antigen
gans and are circulating through the blood, lymph, and presentation. Interestingly, several lines of evidence ar-
secondary lymphoid organs or have accessed the pa- gue that MECs and cortical epithelial cells (CECs) pro-
renchymal tissues in response to some stimulus. Anti- cess or present antigens in distinct ways (Mizuochi et
gens of concern would primarily be those expressed in al., 1992; Kasai et al., 1996, 2000; Oukka et al., 1997).
the tissues and not in the thymus or bone marrow. Clonal MECs have been implicated in the tolerization of mature
deletion and anergy are tolerance mechanisms also em- single-positive (CD48 or CD48) thymocytes in a
ployed in the periphery, but a variety of other means number of systems (Oukka et al., 1996a, 1996b; Kishi-
moto and Sprent, 1997, 1999; Kishimoto et al., 1996;
Klein et al., 1998). Consequently, the notion arose that*Correspondence: cbdm@joslin.harvard.edu
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Figure 1. MEC-Mediated Central Tolerance and Its Control by AIRE/aire
the promiscuous thymic expression of proteins charac- is autoimmune polyendocrinopathy-candidiasis-ecto-
dermal dystrophy (APECED), otherwise known as auto-teristic of peripheral organs might promote tolerance
induction to those organs. As illustrated in Figure 1A, immune polyglandular syndrome type 1 (APS-1) (reviewed
in Vogel et al., 2002). This syndrome is characterized bythe self-proteins would be processed to peptides by the
MECs, the peptides loaded onto MHC molecules, and mucocutaneous candidiasis, hypoparathyroidism, and
the MHC:self-peptide complexes transported to and adrenal insufficiency. In addition, a variety of secondary
displayed on the MEC surface. Differentiating thymo- symptoms can be manifest, differing from patient to
cytes would encounter the surface-displayed com- patient: type 1 diabetes, reproductive organ failure, alo-
plexes, and, should their TCRs recognize them within a pecia, thyroiditis, etc.
particular window of affinity/avidity, they would be dealt APECED is a monogenic disorder, with an autosomal
with in a manner resulting in tolerization of the T cell rep- mode of inheritance, quite unlike that of most other
ertoire. autoimmune diseases, with their baroquely complex ge-
Thus, we are presented with a complex net of mecha- netic influences. APECED is quite rare, although certain
nisms designed to promote a self-tolerant T cell reper- populations (Finns, Sardinians) show an incidence ele-
toire: both central and peripheral modes, entailing a vated to about 1 in 10,000. Finally, it has the intriguing
diversity of cellular mechanics and involving interplay characteristic that its secondary symptoms vary widely
between the central and peripheral elements (display of from individual to individual, even those harboring the
peripheral antigens in the thymus on the one hand and same genetic lesion and seemingly exposed to the same
thymic selection of T regulatory cells that monitor the environment. The gene underlying APECED was local-
periphery on the other hand). Which of these mecha- ized to the q22 region of chromosome 21 and was posi-
nisms dominate? Which might be artifacts of the sys- tionally cloned in 1997 (Nagamine et al., 1997).
tems used to define them? What circumstances bring The protein encoded by the gene responsible for
particular mechanisms into play and exclude others APECED—AIRE in humans, aire in mice—has features
from operation? These questions are difficult ones to evocative of a transcription factor. As concerns its struc-
answer given the sometimes complex, cryptic, and sub- ture, translation of the AIRE gene coding sequences
tle nature of tolerance phenomena. A potentially power- and grouping of the amino acid residues into functional
ful approach to surmounting the difficulties inherent in units reveals a domain organization similar to that of the
dissecting how tolerance can be established and main- Sp100 family of transcription factors, including SAND
tained is to explore how it can break down as a prelude and PHD domains, and nuclear localization and dimer-
to autoimmune disease. We will discuss two illustra- ization signals. Concerning its functional activities, AIRE
tive examples. is localized in the nucleus, has transactivation potential,
can induce transcription from the interferon- promoter
in a cotransfection assay, binds to a transcription factorAPECED and AIRE
(CREB binding protein [CBP]) in vitro, and has beenOne autoimmune disease that has revealed important
information about the importance of central tolerance reported to bind to DNA (although this has been chal-
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lenged) (Kumar et al., 2001). Most recently, AIRE was mal cells. This finding argues against a required role for
aire in dendritic cells of the thymus or periphery, evendemonstrated to have E3 ubiquitin ligase activity
(Uchida et al., 2004), which might explain at least some though this cell-type does express it at significant levels.
A more directed set of studies established that aire doesof its influences on transcription (or might not). More
than 50 mutations of the AIRE protein have been identi- indeed control promiscuous thymic transcription of pe-
ripheral tissue-specific genes (Anderson et al., 2002).fied from the DNA of APECED patients, alterations of
diverse nature (non-sense, missense, deletion) scat- MECs were purified from aire-deficient mice and control
littermates, RNA was isolated, and transcripts were am-tered throughout the protein sequence (Heino et al.,
2001). plified and applied to Affymetrix gene chips. RNA from
MECs expressing aire included numerous transcriptsAn important key to AIRE’s role in promoting tolerance
and preventing autoimmunity came when its pattern of encoding tissue-specific or tissue-restricted proteins,
certain of which (e.g., preproinsulin and p450 1A2) areexpression was established. Data on humans has been
controversial, but clearer results have come from the known targets of autoantibodies detected in APECED
patients. RNA from aire-deficient MECs was strikinglymouse, relying on quantitative assessment of aire gene
transcripts in diverse tissues (Anderson et al., 2002; Got- impoverished in such transcripts. It was estimated that
aire might influence the expression of around a thousandter et al., 2004). The aire gene is transcribed primarily
in lymphoid organs (thymus, lymph node, spleen), and genes in MECs; this value is of the same order of magni-
tude as a recent estimate of the number of promiscu-only at low or undetectable levels in practically all paren-
chymal tissues, including those targeted in APECED ously expressed genes in human MECs (Gotter et al.,
2004). Thus, the hypothesis that aire somehow controlspatients. Aire is, above all, expressed in the thymus,
where transcripts are confined to stromal cells and are the promiscuous thymic transcription of peripheral tis-
sue-specific antigens and that the autoimmune diseasenot detected at a significant level in differentiating thy-
mocytes. Of the diverse stromal cell populations, MECs of APECED patients reflects a defect in this process
would appear to be correct. Proof will come when theexpress the most aire and dendritic cells the next-most.
The pattern of aire gene expression was strikingly similar targets of some of the autoantibodies produced in aire-
deficient mice are identified and are found to be en-to the distribution of promiscuous thymic transcripts
corresponding to peripheral tissue-specific proteins. coded by transcripts downregulated in the MECs of
these animals.This concordance has elicited the hypothesis that AIRE/
aire somehow controls this promiscuous transcription An open question is the cellular mechanism by which
aire exacts its control over T cell tolerance. A logical(Figure 1B) and that APECED patients, owing to their
mutant AIREs, cannot express such transcripts, thereby possibility would be a negative influence—aire-express-
ing MECs would display a diversity of MHC:self-peptidehave a defect in induction of T cell tolerance to tissue-
specific self-antigens, and ultimately develop autoim- complexes on their surface, which could trigger clonal
deletion of differentiating thymocytes whose TCRs rec-mune disease.
To test this hypothesis, two groups have generated ognize them at a particular affinity/avidity. However,
skepticism over such a scenario has been expressed,mice devoid of aire (Ramsey et al., 2002; Anderson et al.,
2002). The immunological phenotoype of these animals largely due to the fact that MECs are a relatively rare
thymus population and to a report contending that anywas surprisingly normal, with quite standard numbers,
subsets, and activities of lymphocytes in both the pri- particular tissue-specific protein is expressed in only a
small fraction (1%) of MECs (Derbinski et al., 2001).mary and secondary lymphoid organs. One difference
noted was that there was a doubling of activated T cells How can so few cells purge the entire emerging T cell
repertoire? Thus, the alternative possibility of aire havingin the periphery, suggestive of autoimmune activation.
Indeed, the aire-deficient mice had lymphocytic infil- a positive influence through positive selection of regula-
tory T cells has been evoked. Such a mechanism wouldtrates in a number of parenchymal tissues and also pro-
duced autoantibodies directed against them. Interest- be in line with reports that expression of a self-antigen
on thymic epithelial cells promoted the emergence ofingly, while there was a broad autoreactivity, in the sense
that many organs were targeted, it was also strikingly CD425 T regulatory cells in two TCR transgenic sys-
tems (Jordan et al., 2001; Apostolou et al., 2002). None-specific, in that within each organ only a particular struc-
ture was attacked, e.g., the rods and cones layer of theless, skepticism over a negative influence might be
considered ill-placed: fully mature thymocytes spend asthe retina or the parietal cell layer of the stomach. The
features of aire-deficient mice are sufficiently similar to much as 2 weeks in the medulla (Scolley and Godfrey,
1995; Rooke et al., 1997), so they have time; thymocytesthose of AIRE-defective humans with APECED that the
former can justifiably serve as a model for dissecting display extremely active motility within the thymus, so
they have the occasion (Bousso et al., 2002); and, last,disease mechanisms.
An initial set of studies established that aire exerts there is precedence for a highly efficient clonal deletion
mechanism in the ability of extremely few splenic den-its control over autoimmunity through its expression in
thymic epithelial cells (Anderson et al., 2002). Irradiation/ dritic cells or thymic hematopoietic cells to cleanse the
thymocyte repertoire (Matzinger and Guerder, 1989;bone marrow chimera experiments demonstrated that
aire function partitioned with radio-resistant stromal Merkenschlager et al., 1994).
Hence, it is important to experimentally address thecells, while thymus transplant experiments showed par-
titioning with the thymus rather than the peripheral cellular mechanism(s) associated with aire function. Us-
ing a double Ag/TCR transgenic system (lysozyme ex-lymphoid organs. In fact, all that was needed for devel-
opment of an autoimmune condition like that of standard pression driven by the rat insulin promoter/an overabun-
dance of lysozyme-specific T cells), Liston et al. (2003)aire-deficient mice was aire’s absence from thymic stro-
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provided evidence in favor of aire control of clonal dele- to transcriptional control. These might affect MEC differ-
entiation, antigen processing or presentation, or chemo-tion of self-reactive thymocytes. Some questions have
been raised about this conclusion concerning, in partic- kine-mediated attractions of thymocytes (e.g., Kwan
and Killeen, 2004).ular, the perhaps too-early timing of deletion or the level
and site of expression of the neo-self-antigen in the Insights into the molecular and cellular pathways that
aire participates in may come from the identification ofthymus. However, experiments of similar design em-
ploying an ovalbumin-based double-transgenic system molecules that impinge on its expression or operation.
Two recent studies have drawn attention to similaritieshave yielded the same conclusion (Anderson et al.,
2004). It remains unknown whether the observed effects in the autoimmune phenotypes of aire-deficient mice
and mice with a defect in the lymphotoxin (LT) pathwayon clonal deletion are direct ones that can be attributed
to MECs themselves or are more indirect, operating via (either LT- or LT  receptor) (Chin et al., 2003; Boehm
et al., 2003). Both studies found a reduction in thymiccrosspresentation through an intermediary antigen-pre-
senting cell of hematopoietic lineage, such as a dendritic expression of aire, but one attributed this to a direct
effect on aire gene transcription (Chin et al., 2003), whilecell or macrophage. A role for aire in inciting negative
selection of thymocytes does not rule out an additional the other invoked an influence on the differentiation of
MECs, i.e., on the number of cells capable of transcrib-activity to promote positive selection of regulatory
T cells. However, aire-deficient mice were reported to ing the aire gene (Boehm et al., 2003). The more careful
analysis of purified MECs (rather than whole thymus)have normal numbers of CD425 T cells in all lymphoid
organs (Anderson et al., 2002; Liston et al., 2003). In in the latter study argues for the latter point of view.
However, the former study did report an acute effectaddition, this population appears to function normally
in the standard in vitro and a variety of in vivo assays of (within 6 hr) on thymic levels of aire (and insulin-1, but
not keratin-14) gene transcripts after systemic engage-regulatory T cell function, the latter including protection
from lymphopenia-induced wasting and colitis in lym- ment of the LT  receptor with an agonistic mAb, a
finding difficult to integrate into the MEC differentiationphocyte transfer experiments as well as multiorgan au-
toimmunity in double-thymic (aire plus aire) transfers scenario. One member of a second cytokine family also
appears to control AIRE expression, at least in vitro:(Venanzi et al., 2004a).
Aire’s molecular mechanism is also an intriguing is- treatment of human dendritic cells with thymic stromal
lymphopoetin (TSLP) activated their antigen presenta-sue. As discussed above, there are many structural and
functional suggestions that aire might act as a transcrip- tion capabilities and turned on AIRE (Watanabe et al.,
2004). The in vivo relevance of this finding remains totion factor (according to the loose definition of a mole-
cule that somehow promotes gene expression). Given be determined, but it was noted that TSLP is also ex-
pressed in Hassal’s corpuscles, a specialized epithelialthat it probably targets several hundreds of genes in
thymic MECs and that these show radically different cell type found in the thymic medulla.
The fascinating nature of the cellular and molecularpatterns of expression in peripheral parenchymal tis-
sues, it seems counterintuitive to suppose that aire machinations of aire have reawakened interest in central
tolerance induction. This single protein has a strongfunctions by binding directly to individual promoter/
impact on immunological tolerance, which reads out asenhancer elements. Some epigenetic mechanism—
a multiorgan autoimmune disease in both humans andinvolving chromosomal imprinting, chromatin acetyla-
mice. Current thought and effort are focused on bettertion, DNA methylation, or chromatin remodeling—would
defining just how aire operates. Yet, intriguing lateralappear to be more likely—in short, some process that
thoughts are also emerging. Why don’t aire-deficientmight turn on or off sets of genes, whether adjacent or
mice show more widespread organ attack? What con-nonadjacent. In support of such a notion, it was recently
trols the expression of promiscuous MEC transcriptsreported that the list of promiscuous transcripts ex-
not regulated by aire—is there an aire-2 or aire-3? Mightpressed in human MECs contains several sets of chro-
mutations in such molecules underlie the related polyen-mosomally clustered loci, including a group of genes
docrine autoimmune disease APS-2? Might mutationsencoding S100 family members and neighbors ulti-
in other elements of the pathway through which airemately expressed in the liver and a group of genes en-
operates, e.g., LT or TSLP, be responsible?coding molecules involved in epidermal cell differentia-
tion (Gotter et al., 2004). Aire-controlled genes in murine
MECs are also preferentially ones that are clustered Type 1 Diabetes
Insulin-dependent diabetes mellitus, or type 1 diabetes,along chromosomes (Venanzi et al., 2004a). This is
clearly an important area for future study, one that is one of the classic examples of an organ-specific auto-
immune disease (for reviews see Bach, 1994; Tisch andseems in its neonatal period.
It is also worth considering whether aire might not McDevitt, 1996). It consists of two stages: an occult
phase, termed insulitis, when a mixed population of leu-function in ways other than to control the promiscuous
transcription of tissue-specific proteins. This possibility kocytes invades the islets of Langerhans of the pan-
creas, eventually provoking specific destruction of theis raised by the fact that aire regulates, either positively
or negatively, a variety of MEC transcripts other than insulin-producing  cells; and an overt phase, diabetes,
when the bulk of  cells has been destroyed and insulinthose encoding peripheral antigens (Anderson et al.,
2002). Included among these are transcripts of chromo- production is no longer sufficient to regulate blood glu-
cose levels, resulting in hyperglycemia. Although auto-somally clustered genes encoding a diversity of MHC
molecules and various chemokines. The newly de- immune diabetes is an ancient and increasingly frequent
disease, we remain surprisingly ignorant of its etiologyscribed E3 ubiquitin ligase activity of aire (Uchida et al.,
2004) also opens the possibility of activities in addition and pathogenesis.
Review
513
Faced with the difficulties of studying disease in hu- in the thymus has lent support to the pathological rele-
vance of this correlation (Chentoufi and Polychronakos,mans, many investigators have turned to small animal
models of type 1 diabetes—in particular, the nonobese 2002) as have the recent findings that mice carrying a
proinsulin-2 gene deletion, and thereby lacking thymicdiabetic (NOD) mouse strain. Developed in the late
1970s, the NOD strain is now the most commonly used insulin expression, develop more aggressive type 1 dia-
betes (promoted by islet-restricted expression of insu-animal model of autoimmune diabetes (for review see
Bach and Mathis, 1997). Disease develops spontane- lin-1) than wild-type mice (Dubois-Lafforgue et al., 2002;
Moriyama et al., 2003). This set of observations might beously in these mice, sharing several critical features with
the human disorder. As in man, the course of pathology considered an antigen-specific manifestation of AIRE’s
influence on central tolerance.in NOD animals is protracted: insulitis begins at about
4 weeks of age, but diabetes is not evident until 15 to An antigen-independent defect in central tolerance
induction has been hypothesized in the case of NOD25 weeks. Again as in man, diabetes in these animals
is primarily T lymphocyte mediated, although other cell mice, i.e., incomplete deletion or anergization of autore-
active cells differentiating in the thymus (Lee et al., 2001;types, like B cells or macrophages, may also play an
important role. Finally, the human and murine diseases Carrasco-Marin et al., 1996), and there now exist multi-
ple lines of experimental data in support of this notion.are both under complex polygenic control, by far the
most important contributor being the major histocom- Initial evidence included the demonstration of unusually
high syngeneic T lymphocyte reactivity (Ridgway et al.,patibility complex (MHC). Strikingly, comparison of the
three-dimensional structure of the NOD MHC class II 1996, 1998; Kanagawa et al., 1998) and unexpected
T cell responses to injected self-antigens (Ridgway etmolecule, Ag7, with those of the human HLA-DQ8 and
-DQ2 class II molecules, both major genetic risk ele- al., 1996, 1998; Kanagawa et al., 1998). However, in
both cases, aberrant peripheral tolerization remained anments for diabetes development, revealed pronounced
similarities in the antigen (Ag) binding pockets, sug- explanation. More recently, abnormal clonal deletion of
NOD thymocytes was reported using two systems. First,gesting that similar autoAg presentation events may pre-
lude diabetes in mice and humans (Lee et al., 2001). The engagement of TCRs by systemic injection of an anti-
CD3 mAb or a superantigen was less effective at induc-NOD mouse strain has permitted many of the outstand-
ing issues in the diabetes field to be addressed by direct ing deletion of NOD than of C57Bl/6 thymocytes (Kishi-
moto and Sprent, 2001), although this result was laterexperimentation, and results on these mice have heavily
colored our view of diabetes pathogenesis. challenged (Villunger et al., 2003). Second, coupling of
a TCR transgenic mouse line with a second transgenicA battery of studies on the NOD mouse has estab-
lished that T lymphocytes are central to disease patho- line expressing cognate antigen in the thymus resulted
in more extensive clonal deletion on the NOD than ongenesis in this model of type 1 diabetes (reviewed in
Adorini et al., 2002; Atkinson and Eisenbarth, 2001). Im- the C57Bl/6 genetic background (Lesage et al., 2002).
Certain of these aberrant properties segregated withmunohistological analyses reveal that most of the leuko-
cytes in the islet infiltrate are T cells, and T lymphocyte NOD MHC genes (Kanagawa et al., 1998; Ridgway et al.,
1998), although the abnormalities in thymocyte deletionautoreactivity to  cells is readily demonstrable. Disease
does not develop in NOD mice genetically athymic or T were specified by non-MHC genes (Kishimoto and
Sprent, 2001; Lesage et al., 2002) and were T cell intrinsiclymphopenic or in mice thymectomized at birth; like-
wise, it is dampened or even abrogated by reagents that (Lesage et al., 2002).
Extensive evidence of ineffective peripheral toleranceinterfere with T cell function. Finally, diabetes can be
transferred by injecting T cells from diseased donors induction/maintenance in NOD mice has also been pro-
vided (Kreuwel et al., 2001; Markees et al., 1999; Quinninto healthy NOD recipients, the least equivocal demon-
stration being inoculation of a single T cell clone into a et al., 2001; Pearson et al., 2003a, 2003b; Molano et al.,
2001; Grohmann et al., 2003; Makhlouf et al., 2002).lymphocyte-deficient NOD mouse. There is ample indi-
cation that the human disease is also mediated by T These abnormalities have usually been associated with
non-MHC loci (Kreuwel et al., 2001; Markees et al., 1999;lymphocytes, exhibiting a similar islet histology, T cell
autoreactivity to  cell antigens, and positive response Quinn et al., 2001). It may be possible that, at least
to some degree, they reflect reported aberrancies into treatment with T cell inhibitors.
The preeminent role of  cell-reactive T lymphocytes numbers and/or activity of regulatory T cell populations
(Gombert et al., 1996; Baxter et al., 1997; Salomon etin type 1 diabetes implies that individuals with this dis-
ease harbor some deficit in the induction and/or mainte- al., 2000; reviewed in Bach and Chatenoud, 2001).
The relative importance of defects in central versusnance of T cell tolerance to self-antigens. An antigen-
dependent defect has been postulated in the case of peripheral tolerization in promoting diabetes in NOD
mice has been heavily debated. However, it is possiblehumans (reviewed in Pugliese and Miceli, 2002). The
only well-established diabetes susceptibility locus out- that, at least in part, the two classes of defect are mani-
festations of the same genetic lesion(s). For example,side the MHC is IDD2, which encompasses the single
human insulin gene. A correlation has been made be- apoptosis plays a role in tolerance induction/mainte-
nance in both the thymus and peripheral lymphoid or-tween the number of copies of a particular repeat se-
quence found at the 5 end of the insulin gene, levels gans, and there have been many reports that apoptosis
or its executors are subnormal in NOD mice (Kishimotoof insulin expression in the thymus, and incidence of
type 1 diabetes. This observation is highly suggestive and Sprent, 2001; Quinn et al., 2001; Penha-Goncalves
et al., 1995; Leijon et al., 1994; Garchon et al., 1994;and interesting, but it remains essentially correlative at
present. Modeling of the human phenomenon by engi- Colucci et al., 1997; Lamhamedi-Cherradi et al., 1998;
Bergman et al., 2001, 2003; Decallonne et al., 2003;neering mice with different levels of insulin expression
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Boehm, T., Scheu, S., Pfeffer, K., and Bleul, C.C. (2003). ThymicArreaza et al., 2003). It is also possible that genetic
medullary epithelial cell differentiation, thymocyte emigration, andvariation that promotes T cell hyporeactivity results in
the control of autoimmunity require lympho-epithelial cross talk vialess efficient central tolerance, but is balanced by less
LTbetaR. J. Exp. Med. 198, 757–769.
aggressive autoimmune attack in the periphery.
Bousso, P., Bhakta, N.R., Lewis, R.S., and Robey, E. (2002). Dynam-
ics of thymocyte-stromal cell interactions visualized by two-photon
Conclusion microscopy. Science 296, 1876–1880.
Thus, of late, we are back to appreciating the important Carrasco-Marin, E., Shimizu, J., Kanagawa, O., and Unanue, E.R.
influence of central mechanisms of tolerance induction. (1996). The class II MHC I-Ag7 molecules from non-obese diabetic
mice are poor peptide binders. J. Immunol. 156, 450–458.This by no means denies the significance of peripheral
Chentoufi, A.A., and Polychronakos, C. (2002). Insulin expressionmechanisms. The fact that aire-deficient mice and AIRE-
levels in the thymus modulate insulin-specific autoreactive T-celldefective humans actually exhibit a rather restrained
tolerance: the mechanism by which the IDDM2 locus may predis-autoimmune disease surely reflects MHC restriction of
pose to diabetes. Diabetes 51, 1383–1390.
autoantigen presentation but just as certainly must be
Chin, R.K., Lo, J.C., Kim, O., Blink, S.E., Christiansen, P.A., Peterson,an indication of the operation of regulatory T cells and
P., Wang, Y., Ware, C., and Fu, Y.X. (2003). Lymphotoxin pathway
other peripheral processes. The multiorgan autoimmune directs thymic Aire expression. Nat. Immunol. 4, 1121–1127.
diseases of mice lacking Foxp3 (Fontenot et al., 2003) Colucci, F., Bergman, M.-L., Penha-Goncalves, C., Cilio, C.M., and
and Foxj1 (Lin et al., 2004) also argue that central and Holmberg, D. (1997). Apoptosis resistance of nonobese diabetic
peripheral tolerance mechanisms should be considered peripheral lymphocytes linked to the Idd5 idabetes susceptibility
region. Proc. Natl. Acad. Sci. USA 94, 8670–8674.as successive barriers, imperfect on their own but pow-
Decallonne, B., van Etten, E., Giulietti, A., Casteels, K., Overbergh,erful in synergy, to autoimmune disease.
L., Bouillon, R., and Mathieu, C. (2003). Defect in activation-induced
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